Quercetin attenuates ischemia reperfusion injury by protecting the blood-brain barrier through Sirt1 in MCAO rats

J Asian Nat Prod Res. 2022 Mar;24(3):278-289. doi: 10.1080/10286020.2021.1949302. Epub 2021 Jul 22.

Abstract

The purpose of the present study was to examine the protective action and mechanisms of quercetin on the blood-brain barrier (BBB) in rats subjected to transient middle cerebral artery occlusion (tMCAO) and reperfusion. Quercetin (10, 30, 50 mg/kg) was intraperitoneally administered at the onset of reperfusion. The results showed that quercetin significantly reduced cerebral infarct volume, neurological deficit, BBB permeability and ROS generation via Sirt1/Nrf2/HO-1 signaling pathway. Moreover, EX527, a selective inhibitor of Sirt1, reversed these neuroprotective effects. Our findings indicate that quercetin has neuroprotective effects against cerebral ischemia-reperfusion injury by protecting BBB through Sirt1 signaling pathway in MCAO rats.

Keywords: Quercetin; Sirt1; blood-brain barrier; ischemic stroke; oxidative stress.

MeSH terms

  • Animals
  • Blood-Brain Barrier / metabolism
  • Brain Ischemia* / drug therapy
  • Infarction, Middle Cerebral Artery / drug therapy
  • Molecular Structure
  • Neuroprotective Agents* / pharmacology
  • Quercetin / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Reperfusion Injury* / drug therapy
  • Sirtuin 1

Substances

  • Neuroprotective Agents
  • Quercetin
  • Sirt1 protein, rat
  • Sirtuin 1